The siRNA-mediated degradation of PCSK9 mRNA effectively blocks the synthesis of PCSK9 protein, offering a new therapeutic approach for treating cardiovascular diseases (13, 14). This evidence concerns the gene PCSK9 and cardiovascular disorder.